The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

Developers

Developer Name Compounds Regimens Trials
Anacor Pharmaceuticals
https://www.anacor.com/
AstraZeneca
https://www.astrazeneca.com/
CDC
https://www.cdc.gov/tb/topic/research/tbtc/
GlaxoSmithKline
http://www.gsk.com/
Global Alliance for TB Drug Development
Institute of Materia Medica
IUATLD, Inc.
http://www.theunion.org/
Lilly TB Drug Discovery Initiative
https://www.lilly.com
Médecins Sans Frontières France
Medecins Sans Frontieres, The Netherlands
https://www.msf.org.uk/content/tb-practecal
Nearmedic Plus LLC
http://www.nearmedic.ru/en/node/466
Otsuka Pharmaceutical Development & Commercialization, Inc.
https://www.otsuka-us.com/discover/opdc
PanACEA
Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
http://www.infectex.ru/
Qurient Co., Ltd
http://www.qurient.com/?lang=en
Sanofi
http://en.sanofi.com/csr/patient/priorities/access_to_care/access_to_medicines/tuberculosis/tuberculosis.aspx
Sequella, Inc
http://www.sequella.com/
St. George's Hospital University of London
University of Illinois at Chicago
http://www.uic.edu/
Weill Medical College of Cornell University